Quick access to key HIV drug hinges on waiver of local clinical trials: Experts
Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three ...
Arrowhead: A First Approval Likely - Jury Still Out On Investment Opportunity
Arrowhead's plozasiran shows promising Phase 3 data for FCS, with potential blockbuster status, but faces competition. Learn ...
FiercePharma3h
Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow
After unlocking commercial supply and enlisting a manufacturing partner earlier this year, Ferring Pharmaceuticals has ...
BioSpace4h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
FiercePharma4h
Argenx widens its Halozyme Therapeutics-partnered net with 4 new targets in $30M license expansion
With a recently acquired FDA nod for its Halozyme Therapeutics-partnered Vyvgat Hytrulo, argenx is looking to take Halozyme’s ...
Daily5h
Gilead Sciences inks pacts with Dr Reddy's Labs, Emcure, Hetero and 3 others for HIV drug Lenacapavir
Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...
Pharmaceutical Technology6h
Enara Bio secures $32.5m for ‘Dark Antigen’ cancer therapies
Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...
Gilead signs agreements to facilitate access to HIV prevention drug
Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs
Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...
newsdrum10h
Emcure Pharma signs pact with Gilead for manufacturing, supply of HIV drug lenacapavir globally
Emcure Pharmaceuticals on Thursday said it has signed a royalty-free voluntary licensing agreement with Gilead Sciences ...
Pharmabiz12h
Gilead's licensing agreement for lenacapavir a move to preserve its monopoly, alleges TWN
Gilead's licensing agreement for lenacapavir a move to preserve its monopoly, alleges TWN: Our Bureau, New Delhi Thursday, October 3, 2024, 12:20 Hrs [IST] Third World Network (TW ...
Pharmabiz13h
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...